Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

May 27, 2021

Study Completion Date

May 27, 2021

Conditions

COVID-19 Infection

Interventions

OTHER

Probiorinse

Nasal irrigations with probiotic twice-daily for a period of fourteen days

OTHER

Saline solution

Nasal irrigations with saline-only twice-daily for a period of fourteen days

Trial Locations (1)

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT04458519 - Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection | Biotech Hunter | Biotech Hunter